|
🇰🇷 Korea NRA on 'Case Studies on Reducing Impurities in Pharmaceuticals (focusing on NDMA)"
|
|
0
|
355
|
May 1, 2025
|
|
Autonomous CPCA Web-based calculator FREE
|
|
33
|
7046
|
April 30, 2025
|
|
N-nitrosoamides - a horse of a different color
|
|
54
|
7624
|
March 6, 2025
|
|
To which nitrosamines does the CPCA apply?
|
|
2
|
620
|
February 6, 2025
|
|
What is CPCA Score for “N-nitroso of 3-Amino-1,2,4-triazole"
|
|
7
|
601
|
January 30, 2025
|
|
Acceptable Intake N-Nitrosobiotin (N-Nitrosamide)
|
|
2
|
353
|
January 13, 2025
|
|
Development of a Simultaneous Analytical Method for Amines Corresponding to 10 Typical Nitrosamines
|
|
0
|
655
|
December 30, 2024
|
|
Formation of Nitroso-Omeprazole
|
|
5
|
2109
|
December 12, 2024
|
|
Hexamethyldisilazane (HMDS) can form Nitrosamine Impurity?
|
|
7
|
653
|
October 29, 2024
|
|
Primeros pasos para evaluar nitrosaminas en medicamentos
|
|
5
|
342
|
September 23, 2024
|
|
N-Nitroso Carbidopa
|
|
2
|
553
|
September 12, 2024
|
|
Can API with amide should considered a potential candidate for forming nitrosamine impurity
|
|
5
|
711
|
September 12, 2024
|
|
Potential Topic for an event concerning obtaining the right level of Nitrosamine Risk Assessment information from your CMOs
|
|
22
|
1768
|
September 5, 2024
|
|
How much Amine and Nitrating agent "Stoichiometric Ratio" required for formation of Nitrosamine impurities?
|
|
3
|
345
|
August 28, 2024
|
|
DMF in API, specification limit in formulation
|
|
5
|
893
|
August 26, 2024
|
|
Nitrosamine impurities of related substances of API's
|
|
7
|
1024
|
August 12, 2024
|
|
N-nitroso Omeprazole
|
|
4
|
1883
|
August 3, 2024
|
|
Control limit of Nitrosamines and N-nitroso compounds
|
|
2
|
515
|
July 8, 2024
|
|
Non-mutagenic, carcinogenic impurities
|
|
3
|
736
|
June 30, 2024
|
|
Tetrazole nitrosamines
|
|
1
|
306
|
June 13, 2024
|
|
Update: EFPIA workflows for Quality Risk management Jun 2024 v03
|
|
2
|
1393
|
June 4, 2024
|
|
AI limit of API having very law MDD
|
|
1
|
373
|
May 27, 2024
|
|
Category 5 NDSRIs- CPCA tool
|
|
2
|
565
|
May 20, 2024
|
|
Nitrosamine in Azathioprine
|
|
4
|
973
|
May 14, 2024
|
|
APIC NA Risk Assessment Template
|
|
5
|
4216
|
May 11, 2024
|
|
Risk Analysis for Ergotamine Tartrate
|
|
4
|
452
|
April 22, 2024
|
|
Nitrosamines: A new systematic review
|
|
8
|
3580
|
April 13, 2024
|
|
AI Limit for Nitroso Nebivolol
|
|
11
|
2956
|
April 3, 2024
|
|
AI difference between FDA and EMA, HC and TGA
|
|
0
|
1231
|
March 22, 2024
|
|
Nitroso amines quantification in drugs which are having MDD Value more than 10.0g/Day
|
|
2
|
482
|
March 20, 2024
|